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dictor of mortality in patients with severe aortic stenosis (AS) and preserved
LV ejection fraction (LVEF). However, its quantification using echocardio-
graphy may be subject to error measurement. The aim of this study is to deter-
mine the prevalence and impact on long-term survival of high Zva, purposely
measured by cardiac catheterization.
Methods and Results: 768 patients with preserved LVEF (>50%) and
severe AS (valve area ≤1cm²) underwent cardiac catheterization. Zva was
derived from catheterization data and calculated using validated formula. Zva
was considered high when > 5 mmHg/mL/m2. Overall, high Zva was found in
42% of all AS patients.
Patients with high Zva were significantly older (p<0.0001), and more often
female (p< 0.0001), they had significantly smaller aortic valve area
(p<0.0001), higher mean gradient (p=0.001), lower indexed stroke volume
(p<0.0001) and cardiac output (p<0.0001), significantly higher LVED filling
pressures (p=0.03), systolic pulmonary artery pressure (p=0.0005), higher
capillary wedge pressure(p=0.006), reduced systemic arterial compliance
(p<0.0001), but higher systemic vascular resistances(p<0.0001).
Ten-year survival was significantly reduced in patients with higher Zva
(50±5%) as compared to those with lower Zva (67±3%; p=0.01). After adjust-
ment for all other risk factors, Zva was independently associated with reduced
long-term survival (hazard ratio [HR] =1.12 95% CI: 1.009-1.22; p=0.03). Of
interest, high Zva remains associated with reduced survival as compared to
low Zva, in patients with normal LV stroke volume, but was no longer signif-
icant in low flow patients (>60mL: 49±8vs. 69±4%, p=0.012; ≤60mL: 49±7
vs. 53±13%, p=0.96). 
Conclusion: In this large cardiac catheterization-based study, high Zva
estimated invasively is frequent in patients with severe AS, and appears as a
robust and independent predictor of survival. 
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Life expectancy of patients with Marfan syndrome has increased, due to
earlier diagnosis, better familial screening, regular follow-up (FU) and timely
prophylactic aortic surgery (PASu). Incidence of aortic events in affected
patients recognized during childhood is unknown. 
Methods: 465 patients with Marfan syndrome, diagnosed before 18 year-
old between 1993 and 2013 were included in the French multicenter database.
Cardio-vascular events (death, aortic dissection or PASu) were recorded
Results: FU was complete for 69.5%. A cardio-vascular event occurred in
25 patients (5.4% 95CI 3.5-7.8%), including PASu (n=20, 4.3% 95CI 2.5-
6.2%), aortic dissection (n=3, 0.6% 95CI 0.0-1.4%) and deaths (n=2, 0.4% 95CI
0.0-1.0%). 16 events (64%) occurred before 19 year-old (Median 15.0, min 2.8,
interquartile 11.7-16.3; PASu n=12, deaths n=2 and dissection n= 2). One
sudden death occurred in a 18 y.o. girl followed until the age of 14.3 under beta-
blockade treatment. A 3.4 year-old boy with a FBN1 mutation diagnosed at the
age of 1.1 died from respiratory distress and viral myocarditis.
An aortic surgery was performed in 23 patients (4.9%, 95CI 3.0-6.9%),
including a Bentall procedure with mechanical aortic valve in 10 (43.5%), a
valve sparing surgery in the remaining 13 (56.5%) and a supra-coronary graft
in 4 (17.4%, dissection: n=2 and PASu: n=2). Mean age at the date of PASu
was 17.1±6.5 year-old
Events occurred before or at inclusion in the database in 8 patients
(32.0%) (PASu n=5, dissection n=2, death n=1). Dissection was observed
before inclusion in 2 patients out of 3 and during pregnancy in 1 patient
aged 25 and lost of FU until 19 year-old. Kaplan-Meier survival estimate
indicates that 95% of patients remained free from events at eighteen and
78% at thirty year-old.
Conclusion: Prophylactic surgery for enlarged aorta is the main cause of
cardiac events in patients with Marfan syndrome diagnosed during childhood.
A quarter of them have a cardiac event before thirty year-old (figure next
page). 
0031
Performance of systematic search for present and potential portals of
entry of infective endocarditis
François Delahaye (1), Ali M'Hammedi (1), Florence Ader (1), Guy De
Gevigney (1), Anne-Marie Antchouey (2), André Boibieux (1), François
Vandenesch (1)
(1) CHU Lyon Hôpital Louis Pradel, Bron, France – (2) Université des
Sciences de la Santé, Cardiologie, Libreville, Gabon
Infective endocarditis (IE) is a severe disease, with an in-hospital mortality
around 20%. 10% of the patients will have another episode of IE. Thus,
looking for and treating the portal of entry of IE is particularly important. Yet,
literature on this topic is nonexistent.
Since January 2005, we have been prospectively enrolling patients hospi-
talized for certain IE (Duke-Li criteria) in the International Collaboration on
Endocarditis database. Since then, we have been systematically looking for
and treating the portal of entry of the present IE episode and potential portals
of entry of a new IE episode.
Among 444 patients hospitalized in our institution between 2005 and 2011,
318 were included in the present study (exclusion of patients who died during
hospitalization; some medical charts unavailable for technical reasons).
Portal of entry of the present IE episode was identified in 238 patients
(74%). Distribution of identified portals of entry was: cutaneous: 44%
(healthcare-associated: 21%; community-acquired: 13%; IV drug use: 9%);
oral / dental: 29%; gastrointestinal: 22%; genitourinary: 3%; ENT: 2%;
respiratory: 1%.
Potential portals of entry were: continuation of IV drug use in 21 patients
and a cutaneous disease in 2 patients; oral / dental infective foci in 66 / 125
patients with stomatologic examination; colonic lesions (polyps, diverticu-
losis, adenocarcinoma) in 32 / 80 patients in whom colonoscopy was per-
formed because they were ≥50 years old or they had a familial history of
colonic polyposis; genitourinary lesions (prostatic cancer or hyperplasia, ure-
thral stenosis...) in 32 / 52 patients with genitourinary examination; ENT
lesions (sinusitis, otomastoidosis...) in 6 / 180 examinations.
In conclusion, systematic search for the portal of entry of IE was successful
in as many as ¾ of patients. Systematically searching for a potential oral /
dental, gastrointestinal or genitourinary portal of entry of a new IE episode
was also successful in a lot of patients.
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Introduction and objectives: There have few studies conducted in the
past that focus on the significance of congestive heart failure in patients with
prosthetic valve endocarditis. We studied the incidence of congestive heart
failure in patients with prosthetic valve endocarditis and analyzed its profileI,
and we addressed the prognostic significance of heart failure in patients with
prosthetic valve endocarditis.
